Jon P. Mochel

Co-Founder of LEAH Labs, a YC Company at LEAH Labs

Jon P. Mochel has an extensive work experience in the field of veterinary pharmacology and toxicology. Jon P. began their career in 2009 at Novartis as a Pharmacology Modeler Integrated Quantitative Sciences, and later moved into the role of Senior Pharmacology Modeler Integrated Quantitative Sciences. In 2013, they became a European Veterinary Specialist in Pharmacology and Toxicology with the European Board of Veterinary Specialisation. In 2015, they were appointed Chair of the Education and Residency Committee with the European College of Veterinary Pharmacology and Toxicology. In 2016, they joined Iowa State University College of Veterinary Medicine as an Associate Professor of Systems Pharmacology, and in 2018 they became a Co-Founder of LEAH Labs, a Y Combinator Company. In 2019, they became Co-Founder and COO of 3D Health Solutions, Inc. In 2021, they were named a 2021 Marquis Who's Who Entrepreneur in America and a Marquis Who's Who Top Doctor in America. In 2022, they were inducted into Sigma Xi, The Scientific Research Honor Society.

Jon P. Mochel has a diverse educational background. Jon P. attended Y Combinator in W2019. Jon P. then obtained a PhD in Modeling and Simulation Pharmacology from Leiden University in 2014. In 2013, they obtained an EBVS recognized Speciality in Pharmacology and Toxicology from the European Board of Pharmacology & Toxicology. In 2009, they obtained a Master of Science (MSc) in Pharmacology and Pharmacokinetics from Universit\u00e9 Paul Sabatier Toulouse III. In 2008, they completed a Clinical Internship in Veterinary Medicine and Surgery from \u00c9cole nationale v\u00e9t\u00e9rinaire d'Alfort - EnvA. In 2007, they obtained a Doctorate in Veterinary Medicine from \u00c9cole nationale v\u00e9t\u00e9rinaire d'Alfort - EnvA. In 2006, they obtained a Master's degree (M1) in Pathophysiology of Infectious diseases from Universit\u00e9 Paul Sabatier Toulouse III and a Master's degree (M1) in Pharmacology from Universit\u00e9 Paul Sabatier Toulouse III. In 2006, they obtained a Veterinary Degree (DEFV) from Ecole Nationale V\u00e9t\u00e9rinaire de Toulouse. In 2004, they obtained a Master's Degree in Pharmacology from Universit\u00e9 Paul Sabatier Toulouse III. Additionally, they have obtained various certifications from different institutions.

Links

Previous companies

Novartis logo